Health Canada

RSS

PBI-4050 granted U.S. orphan drug status for IPF

Feb. 18, 2015

Health Canada updates Zelboraf labeling to advise of pancreatitis risk

Feb. 13, 2015

ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes

Jan. 29, 2015

Tekmira authorized to start phase I trial of RNAi therapeutic for HBV infection

Dec. 29, 2014

Health Canada clears Immunovaccine to conduct phase II trial of DPX-Survivac

Nov. 20, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

FDA and Health Canada permit expanded access administration of Tekmira's TKM-Ebola

Sep. 23, 2014

Nexavar approved in Canada for differentiated thyroid cancer

July 8, 2014

Antibe Therapeutics receives Canadian clearance to begin phase I program for ATB-346

June 23, 2014

Health Canada accepts Ravicti NDS for priority review

June 4, 2014